Cargando…
Adherence to topical anti-glaucoma medications in Sidama regional state, Southern Ethiopia
PURPOSE: To assess the proportion of adherence to topical anti-glaucoma medications and associated factors among glaucoma patients in Sidama regional state, Ethiopia. METHODS: An institution based cross-sectional study was conducted from May 30 to July 15, 2022 at Hawassa University comprehensive sp...
Autores principales: | , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10132528/ https://www.ncbi.nlm.nih.gov/pubmed/37099553 http://dx.doi.org/10.1371/journal.pone.0284200 |
_version_ | 1785031400052752384 |
---|---|
author | Melaku, Mekete Wodajnew Yibekal, Betelhem Temesgen Demilew, Ketemaw Zewdu |
author_facet | Melaku, Mekete Wodajnew Yibekal, Betelhem Temesgen Demilew, Ketemaw Zewdu |
author_sort | Melaku, Mekete Wodajnew |
collection | PubMed |
description | PURPOSE: To assess the proportion of adherence to topical anti-glaucoma medications and associated factors among glaucoma patients in Sidama regional state, Ethiopia. METHODS: An institution based cross-sectional study was conducted from May 30 to July 15, 2022 at Hawassa University comprehensive specialized and Yirgalem General Hospitals in Sidama regional state, Ethiopia. A systematic random sampling method was used to select 410 study participants. An adapted eight-item self-reported questionnaire was used to assess adherence. Binary logistic regression was used to identify factors associated with adherence to topical anti-glaucoma medications. Variables with a p-value of <0.05 under multivariable analysis were taken as statistically significant factors for adherence. The strength of the association was measured by using an adjusted odds ratio with 95% confidence interval. RESULTS: A total of 410 participants were included giving a response rate of 98.3%. Those who were adherent to their medications were 221(53.9%) (95% CI: 48.8–58.5). Urban residence (AOR = 2.81: 95% CI = 1.34–5.87), higher educational level (AOR = 3.17: 95% CI = 1.24–8.09), monthly follow-up frequency (AOR = 3.30: 95% CI = 1.79–6.11) and normal vision (AOR = 6.58: 95% CI = 3.03–10.84) were significantly associated with adherence. CONCLUSION: More than half of glaucoma patients attending at Hawassa University comprehensive specialized and Yirgalem general hospitals were adherent to their topical anti-glaucoma medications. Urban residence, educational level, follow-up frequency, and normal vision were associated with adherence. |
format | Online Article Text |
id | pubmed-10132528 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | Public Library of Science |
record_format | MEDLINE/PubMed |
spelling | pubmed-101325282023-04-27 Adherence to topical anti-glaucoma medications in Sidama regional state, Southern Ethiopia Melaku, Mekete Wodajnew Yibekal, Betelhem Temesgen Demilew, Ketemaw Zewdu PLoS One Research Article PURPOSE: To assess the proportion of adherence to topical anti-glaucoma medications and associated factors among glaucoma patients in Sidama regional state, Ethiopia. METHODS: An institution based cross-sectional study was conducted from May 30 to July 15, 2022 at Hawassa University comprehensive specialized and Yirgalem General Hospitals in Sidama regional state, Ethiopia. A systematic random sampling method was used to select 410 study participants. An adapted eight-item self-reported questionnaire was used to assess adherence. Binary logistic regression was used to identify factors associated with adherence to topical anti-glaucoma medications. Variables with a p-value of <0.05 under multivariable analysis were taken as statistically significant factors for adherence. The strength of the association was measured by using an adjusted odds ratio with 95% confidence interval. RESULTS: A total of 410 participants were included giving a response rate of 98.3%. Those who were adherent to their medications were 221(53.9%) (95% CI: 48.8–58.5). Urban residence (AOR = 2.81: 95% CI = 1.34–5.87), higher educational level (AOR = 3.17: 95% CI = 1.24–8.09), monthly follow-up frequency (AOR = 3.30: 95% CI = 1.79–6.11) and normal vision (AOR = 6.58: 95% CI = 3.03–10.84) were significantly associated with adherence. CONCLUSION: More than half of glaucoma patients attending at Hawassa University comprehensive specialized and Yirgalem general hospitals were adherent to their topical anti-glaucoma medications. Urban residence, educational level, follow-up frequency, and normal vision were associated with adherence. Public Library of Science 2023-04-26 /pmc/articles/PMC10132528/ /pubmed/37099553 http://dx.doi.org/10.1371/journal.pone.0284200 Text en © 2023 Melaku et al https://creativecommons.org/licenses/by/4.0/This is an open access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/) , which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. |
spellingShingle | Research Article Melaku, Mekete Wodajnew Yibekal, Betelhem Temesgen Demilew, Ketemaw Zewdu Adherence to topical anti-glaucoma medications in Sidama regional state, Southern Ethiopia |
title | Adherence to topical anti-glaucoma medications in Sidama regional state, Southern Ethiopia |
title_full | Adherence to topical anti-glaucoma medications in Sidama regional state, Southern Ethiopia |
title_fullStr | Adherence to topical anti-glaucoma medications in Sidama regional state, Southern Ethiopia |
title_full_unstemmed | Adherence to topical anti-glaucoma medications in Sidama regional state, Southern Ethiopia |
title_short | Adherence to topical anti-glaucoma medications in Sidama regional state, Southern Ethiopia |
title_sort | adherence to topical anti-glaucoma medications in sidama regional state, southern ethiopia |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10132528/ https://www.ncbi.nlm.nih.gov/pubmed/37099553 http://dx.doi.org/10.1371/journal.pone.0284200 |
work_keys_str_mv | AT melakumeketewodajnew adherencetotopicalantiglaucomamedicationsinsidamaregionalstatesouthernethiopia AT yibekalbetelhemtemesgen adherencetotopicalantiglaucomamedicationsinsidamaregionalstatesouthernethiopia AT demilewketemawzewdu adherencetotopicalantiglaucomamedicationsinsidamaregionalstatesouthernethiopia |